| Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings E Thodou, SL Asa, G Kontogeorgos, K Kovacs, E Horvath, S Ezzat The Journal of Clinical Endocrinology & Metabolism 80 (8), 2302-2311, 1995 | 467 | 1995 |
| Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas E Thodou, G Kontogeorgos, D Theodossiou, M Pateraki Journal of clinical pathology 59 (3), 274-279, 2006 | 82 | 2006 |
| Intrasellar chordomas mimicking pituitary adenoma E Thodou, G Kontogeorgos, BW Scheithauer, I Lekka, S Tzanis, ... Journal of neurosurgery 92 (6), 976-982, 2000 | 64 | 2000 |
| Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas E Thodou, T Argyrakos, G Kontogeorgos HORMONES-ATHENS- 6 (3), 227, 2007 | 35 | 2007 |
| Immunocytochemical accumulation of p53 in corticotroph adenomas: relationship with heat shock proteins and apoptosis G Kontogeorgos, N Kapranos, E Thodou, D Sambaziotis, S Tsagarakis Pituitary 1, 207-212, 1999 | 22 | 1999 |
| The gonadotroph origin of null cell adenomas G Kontogeorgos, E Thodou Hormones 15 (2), 243-247, 2016 | 20 | 2016 |
| Prolactin-producing pituitary adenoma with incomplete neuronal transformation: an intermediate adenoma–neuronal tumor E Thodou, G Kontogeorgos, E Horvath, K Kovacs Acta Neuropathologica 108, 115-120, 2004 | 18 | 2004 |
| Insights into the role of telomeres in human embryological parameters. Opinions regarding IVF G Anifandis, M Samara, M Simopoulou, CI Messini, K Chatzimeletiou, ... Journal of Developmental Biology 9 (4), 49, 2021 | 15 | 2021 |
| Morphology methods: Cell and molecular biology techniques RV Lloyd Springer Science & Business Media, 2001 | 15 | 2001 |
| Somatostatin receptor profile in pituitary thyrotroph adenomas E Thodou, G Kontogeorgos Clinical Neurology and Neurosurgery 195, 105865, 2020 | 12 | 2020 |
| Asynchronous pituitary adenomas with differing morphology. E Thodou, G Kontogeorgos, E Horvath, K Kovacs, HS Smyth, S Ezzat Archives of pathology & laboratory medicine 119 (8), 748-750, 1995 | 12 | 1995 |
| Challenges in cytology specimens with Hürthle cells E Thodou, S Canberk, F Schmitt Frontiers in Endocrinology 12, 701877, 2021 | 11 | 2021 |
| High-risk pituitary adenomas and strategies for predicting response to treatment G Kontogeorgos, E Thodou, RY Osamura, RV Lloyd Hormones 21 (1), 1-14, 2022 | 10 | 2022 |
| The art and applications of fluorescence in situ hybridization in endocrine pathology G Kontogeorgos Endocrine Pathology 11, 123-136, 2000 | 8 | 2000 |
| MGMT immunohistochemistry in pituitary tumors: controversies with clinical implications G Kontogeorgos, E Thodou, M Koutourousiou, G Kaltsas, A Seretis Pituitary 22, 614-619, 2019 | 7 | 2019 |
| A serum-free system for primary cultures of human pituitary adenomas E Thodou, L Ramyar, AI Cohen, W Singer, SL Asa Endocrine Pathology 6, 289-299, 1995 | 7 | 1995 |
| Association of pathology markers with somatostatin analogue responsiveness in acromegaly G Kontogeorgos, V Markussis, E Thodou, E Kyrodimou, T Choreftaki, ... International Journal of Endocrinology 2022 (1), 8660470, 2022 | 6 | 2022 |
| Hodgkin lymphoma mimicking inflammatory breast carcinoma: a rare case with diagnostic challenge and novel treatment E Thodou, M Befani, G Triantafyllidis, T Choreftaki, G Kanellis, ... Case Reports in Hematology 2019 (1), 9256807, 2019 | 6 | 2019 |
| Is MGMT the best marker to predict response of temozolomide in aggressive pituitary tumors? Alternative markers and prospective treatment modalities G Kontogeorgos, E Thodou Hormones 18 (4), 333-337, 2019 | 5 | 2019 |
| Hypoxia-inducible Factor-2-altered urothelial carcinoma: clinical and genomic features PJ Vlachostergios, IA Tamposis, M Anagnostou, M Papathanassiou, ... Current Oncology 29 (11), 8638-8649, 2022 | 3 | 2022 |
George Kontogeorgos MD, PhDResearch Associate - Endocrinology, National and Kapodistrian University of Athens, GreeceVerified email at med.uoa.gr
